Cardiff Oncology
CRDF
CRDF
53 hedge funds and large institutions have $8.81M invested in Cardiff Oncology in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
74% less call options, than puts
Call options by funds: $34K | Put options by funds: $129K
Holders
53
Holding in Top 10
–
Calls
$34K
Puts
$129K
Top Buyers
| 1 | +$116K | |
| 2 | +$93K | |
| 3 | +$81.7K | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$48.9K |
| 5 |
Two Sigma Advisers
New York
|
+$43.1K |
Top Sellers
| 1 | -$1.07M | |
| 2 | -$371K | |
| 3 | -$277K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$144K |
| 5 |
Millennium Management
New York
|
-$81.1K |